Glaucoma
Glaucoma A Major Cause of Irreversible Blindness
Prevalence of Glaucoma The Silver Tsunami Is Coming
The Majority of People With Glaucoma Remain Undiagnosed
Glaucoma A Disease With No Early-Warning Symptoms and Subtle Early Signs
Identify High-Risk Populations Many People Are Unaware of Their Risk
Elevated IOP is a Major Risk Factor
Assessment of IOP in the Office Provides Limited Information
IOP Measurement The Basis for Diagnosing Glaucoma and Evaluating Therapeutic Response
IOP Measurement: GAT vs DCT
On the Path to 24-Hour IOP Measurement
Setting Target IOP Can Slow Vision Loss and Prevent Progression of Optic Nerve Damage
Single-Agent Medications Used to Treat Glaucoma
Fixed-Combination Medications Used to Treat Glaucoma
PGAs: First-Line Treatment for Glaucoma
The Ocular Hypertension Treatment Study High-Risk Patients May Need More Medications
Adverse Effects of Medications Used to Treat Glaucoma
"Golden Rules" For Improving Medication Adherence
Local Ocular Effects of Some Eye Drops
Systemic Adverse Effects of Glaucoma Drugs
Emerging Therapies for Glaucoma
Concluding Remarks
Abbreviations